| Application no. and date | 20169707.5 (espacenet) (Federated) (European Patent Register), 20151116 | | Patent/reg. no. and date | DK/EP 3699181, 20230301 | | Publication date | 20200826 | | Priority no. and date | US 201462080374 P, 20141116, US 201562169545 P, 20150601 | | EP pub. no. and date |
EP 3699181 20200826 | | Effective date | | | Applicant/owner | Array BioPharma Inc., 3200 Walnut Street
Boulder, CO 80301, US | | Applicant ref. no. | V2303-006-DK | | Inventor | SHAH, Khalid, 12 Amberwood Circle
South San Francisco, CA 94080, US,
ARRIGO, Alisha B., Array Biopharma, Inc
3200 Walnut Street
Boulder, CO 80301, US,
JUENGST, Derrick, Array Biopharma, Inc.
3200 Walnut Street
Boulder, CO 80301, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61P 35/00 (2006.01) , C07D 487/04 (2006.01) | | Title | KRYSTALLINSK FORM AF (S)-N-(5-((R)-2-(2,5-DIFLUORPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDIN-1-CARBOXAMIDHYDROGENSULFAT | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
